The Impact Of Nicotinic acid (Niacin) And Laropiprant (LRPT) On Increased Triglyceride more than 300 And its implications with low High Density Lipoprotein Cholesterol (males less than 40 females less than 45)

Trial Profile

The Impact Of Nicotinic acid (Niacin) And Laropiprant (LRPT) On Increased Triglyceride more than 300 And its implications with low High Density Lipoprotein Cholesterol (males less than 40 females less than 45)

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Niacin/laropiprant (Primary)
  • Indications Hypertriglyceridaemia
  • Focus Therapeutic Use
  • Acronyms PURSE HIS
  • Most Recent Events

    • 04 Nov 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top